-$356 Loss
ARTLLong Stock
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. VERY bad trade...
Broker:Interactive Brokers
| Date | Price | |
|---|---|---|
| Entry | 2/12/2021 | 3.00 |
| Exit | 2/12/2021 | 2.7034 |
- Total Views36
- Position Size1,200
- Percentage-9.89%
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
